Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraoral Administration of Onabotulinum Toxin A for Continuous Neuropathic Pain: a Single Subject Experimental Design

NCT03848143 is registered in ClinicalTrials.gov with Isabel Moreno Hay as lead sponsor.

NCT NCT03848143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03848143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraoral Administration of Onabotulinum Toxin A for Continuous Neuropathic Pain: a Single Subject Experimental Design
Lead sponsor
Isabel Moreno Hay
Phase
Phase 2
Overall status
Completed
Start date
September 11, 2019
Completion date
June 30, 2025
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathic pain